These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10093634)

  • 1. Socioeconomic status and cancer incidence and survival.
    Goel V
    Cancer Prev Control; 1998 Oct; 2(5):211-2. PubMed ID: 10093634
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between socioeconomic status and cancer incidence in Toronto, Ontario: possible confounding of cancer mortality by incidence and survival.
    Gorey KM; Holowaty EJ; Laukkanen E; Fehringer G; Richter NL
    Cancer Prev Control; 1998 Oct; 2(5):236-41. PubMed ID: 10093638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some interpretation of regional estimates of the incidence of cancer in France over the period 1980--2005].
    Colonna M; Bossard N; Mitton N; Remontet L; Belot A; Delafosse P; Grosclaude P;
    Rev Epidemiol Sante Publique; 2008 Dec; 56(6):434-40. PubMed ID: 19010627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation in the diagnosis of cancer: a study based on national cancer registration in Sweden.
    Lambe M; Blomqvist P; Bellocco R
    Br J Cancer; 2003 May; 88(9):1358-60. PubMed ID: 12778061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer rates and deaths from cancers continued to decline between 1992 and 1998.
    Health Care Strateg Manage; 2001 Jul; 19(7):7-8. PubMed ID: 11464573
    [No Abstract]   [Full Text] [Related]  

  • 7. Associations between socioeconomic status and cancer survival: choice of SES indicator may affect results.
    Zhang-Salomons J; Qian H; Holowaty E; Mackillop WJ
    Ann Epidemiol; 2006 Jul; 16(7):521-8. PubMed ID: 16386924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical studies in the aetiology of malignant neoplasms. 3.
    Clemmesen J
    Acta Pathol Microbiol Scand Suppl; 1969; 209():Suppl 209:1+. PubMed ID: 5267218
    [No Abstract]   [Full Text] [Related]  

  • 9. Socioeconomic status and childhood solid tumor and lymphoma incidence in Canada.
    Mezei G; Borugian MJ; Spinelli JJ; Wilkins R; Abanto Z; McBride ML
    Am J Epidemiol; 2006 Jul; 164(2):170-5. PubMed ID: 16524952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in Ireland, 1994.
    Comber H
    Ir Med J; 1997; 90(5):170, 172. PubMed ID: 9345822
    [No Abstract]   [Full Text] [Related]  

  • 11. U.S. cancer incidence: prostate cancer and breast cancer are most common.
    J Environ Health; 2004 Mar; 66(7):61, 63. PubMed ID: 15032116
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experts debate message sent by increased cancer survival rates.
    Twombly R
    J Natl Cancer Inst; 2004 Oct; 96(19):1412-3. PubMed ID: 15467025
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
    Leu M; Reilly M; Czene K
    J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report: prostate cancer, breast cancer leading newly diagnosed cancers.
    FDA Consum; 2005; 39(1):7. PubMed ID: 15803586
    [No Abstract]   [Full Text] [Related]  

  • 16. [The risk of cancer in the Netherlands].
    Kiemeney LA; Lemmers FA; Verhoeven RH; Aben KK; Honing C; de Nooijer J; Peeters PH; Visser O; Vlems FA
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2233-41. PubMed ID: 19009811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programs].
    Ottó S; Kásler M
    Magy Onkol; 2005; 49(2):99-101, 103-7. PubMed ID: 16249804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chapter 5.4: major public health problems - cancer.
    Barlow L
    Scand J Public Health Suppl; 2006 Jun; 67():78-86. PubMed ID: 16762901
    [No Abstract]   [Full Text] [Related]  

  • 19. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
    Giovannucci E
    Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary lymphatic disruption does not increase risk of breast carcinoma.
    Gansler T; Jemal A
    Breast J; 2009; 15(4):438-9. PubMed ID: 19470136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.